ORGOVYX RELUGOLIX 瑞格列克

‌Reglitaq‌ is an atypical antipsychotic drug mainly used to treat ‌schizophrenia‌. It regulates the balance of neurotransmitters by antagonizing dopamine D2 and 5-hydroxytryptamine (5-HT2A) receptors, and improves positive symptoms (such as hallucinations, delusions) and negative symptoms (such as apathy). It must be used strictly in accordance with the doctor’s instructions and monitor adverse reactions regularly.

1. Indications and Mechanism of Action
‌Indications‌:
Acute and maintenance treatment of schizophrenia.
It may be used to control symptoms related to bipolar disorder (doctor evaluation required).
‌Mechanism of Action‌:
Reducing positive symptoms by antagonizing dopamine D2 receptors;
Antagonizing 5-HT2A receptors, improving negative symptoms and cognitive function.
2. Precautions for Use
‌Prescription Drug Specifications‌: Prescriptions must be issued after evaluation by a psychiatrist, and the dose cannot be adjusted or discontinued on your own.
‌Dose Adjustment‌: The initial dose is usually low and is gradually adjusted according to efficacy and tolerability.
‌Long-term monitoring‌: Regularly check metabolic indicators (such as blood sugar, blood lipids), electrocardiograms and weight changes.
3. Common side effects and treatments ‌Common reactions‌:
Sleepiness, dizziness, weight gain;
Constipation, dry mouth, akathisia (restlessness).
‌Serious risks‌:
Tardive dyskinesia (uncontrollable muscle activity after long-term use);
Metabolic syndromes such as hyperglycemia and dyslipidemia.
If chest pain, high fever or muscle stiffness occurs, seek medical attention immediately.
4. Contraindications and special populations ‌Contraindications‌: People who are allergic to drug ingredients, patients with severe cardiovascular diseases, and patients with Parkinson’s disease are prohibited.
‌Special populations‌: Pregnant women and breastfeeding women need to assess the risk before taking the drug;
Elderly patients may need to reduce the dose to prevent falls or cognitive decline.
5. Patient medication guidance ‌Compliance‌: Adhere to regular medication to avoid symptom rebound caused by sudden cessation.
‌Lifestyle‌: Combine healthy diet and moderate exercise to reduce metabolic side effects. ‌Review reminder‌: Psychiatric review and biochemical index review every 3-6 months.
The use of Regliox requires individualized treatment under the guidance of a doctor. Abnormal symptoms during treatment should be reported in a timely manner to ensure safety and efficacy.